News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biomics Biotechnologies and Benitec, Inc. (BLT.AX) Advance RNAi Treatment for Hepatitis B



2/22/2011 11:13:36 AM

February 22, 2011 -- Biomics Biotechnologies of Nantong and Benitec Limited of Australia agreed to advance their hepatitis B anti-viral collaboration into in vivo pre-clinical studies. The two companies are seeking to identify an RNA interference (RNAi) treatment for hepatitis B. Both companies are RNAi specialists. More details....

Stock Symbol: (ASX: BLT)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES